It looks like Clarus Ventures is planning to reload with investment capital for life science companies.
The Boston- and San Francisco-based venture firm revealed in a SEC filing it’s looking to raise up to $375 million for a third fund.
SUBSCRIBE
Biohealth Innovation
Founding Member of
